Filing Details
- Accession Number:
- 0001209191-20-057612
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-10 16:10:39
- Reporting Period:
- 2020-11-09
- Accepted Time:
- 2020-11-10 16:10:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Surgical & Medical Instruments & Apparatus (3841) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1661715 | Lisa Evoli | 1100 Campus Road Princeton NJ 08540 | Executive Vice President &Chro | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-11-09 | 754 | $51.00 | 7,502 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-11-09 | 4,424 | $32.59 | 11,926 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-09 | 4,424 | $51.00 | 7,502 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-11-09 | 2,552 | $43.68 | 10,054 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-09 | 2,552 | $55.18 | 7,502 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-09 | 4,424 | $0.00 | 4,424 | $32.59 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-09 | 2,552 | $0.00 | 2,552 | $43.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-03-14 | No | 4 | M | Direct | |
1,785 | 2025-03-13 | No | 4 | M | Direct |
Footnotes
- 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/14/2016.
- This stock option was previously reported as covering 2,212 shares of common stock at an exercise price of $65.17 per share. In accordancewith the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflectthe two-for-one stock split that occurred on December 21, 2016.
- 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/13/2017.